NCT02317744View on ClinicalTrials.gov

Treatment of Binge Eating Disorder in Obesity: Naltrexone/ Bupropion Combination Versus Placebo

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Binge Eating Disorder
Interventions
DRUG

Naltrexone and bupropion combination

OTHER

Pill Placebo

Trial Locations (1)

06520

Yale School of Medicine, New Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT02317744 - Treatment of Binge Eating Disorder in Obesity: Naltrexone/ Bupropion Combination Versus Placebo | Biotech Hunter | Biotech Hunter